These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 34215909

  • 21. Status Epilepticus due to Asfotase Alfa Interruption in Perinatal Severe Hypophosphatasia.
    Ogawa E, Shimura K, Yoshihashi H, Miyama S.
    Pediatr Neurol; 2022 May; 130():4-6. PubMed ID: 35303588
    [Abstract] [Full Text] [Related]

  • 22. Effect of Asfotase Alfa on Muscle Weakness in a Japanese Adult Patient of Hypophosphatasia with Low ALP Levels.
    Koyama H, Yasuda S, Kakoi S, Ohata Y, Shimizu Y, Hasegawa C, Hayakawa A, Akiyama T, Yagi T, Aotani D, Imaeda K, Ozono K, Kataoka H, Tanaka T.
    Intern Med; 2020 Mar 15; 59(6):811-815. PubMed ID: 31787692
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Asfotase Alfa Treatment Improves Survival for Perinatal and Infantile Hypophosphatasia.
    Whyte MP, Rockman-Greenberg C, Ozono K, Riese R, Moseley S, Melian A, Thompson DD, Bishop N, Hofmann C.
    J Clin Endocrinol Metab; 2016 Jan 15; 101(1):334-42. PubMed ID: 26529632
    [Abstract] [Full Text] [Related]

  • 25. Impressive clinical improvement and disappearance of neuropathic pain in an adult patient with hypophosphatasia treated with asfotase alfa.
    Zervou Z, Plooij R, van Velsen EFS, Timmermans RGM, Demirdas S, Zillikens MC.
    Eur J Med Genet; 2024 Apr 15; 68():104915. PubMed ID: 38325645
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Profile of asfotase alfa in the treatment of hypophosphatasia: design, development, and place in therapy.
    Bowden SA, Foster BL.
    Drug Des Devel Ther; 2018 Apr 15; 12():3147-3161. PubMed ID: 30288020
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Improvement of bone microarchitecture parameters after 12 months of treatment with asfotase alfa in adult patient with hypophosphatasia: Case report.
    Freitas TQ, Franco AS, Pereira RMR.
    Medicine (Baltimore); 2018 Nov 15; 97(48):e13210. PubMed ID: 30508901
    [Abstract] [Full Text] [Related]

  • 32. Hypophosphatasia: An overview For 2017.
    Whyte MP.
    Bone; 2017 Sep 15; 102():15-25. PubMed ID: 28238808
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Ectopic Ocular Surface Calcification in Patients With Hypophosphatasia Treated With Asfotase Alfa.
    Gospe SM, Santiago-Turla C, DeArmey SM, Cummings TJ, Kishnani PS, Bhatti MT.
    Cornea; 2019 Jul 15; 38(7):896-900. PubMed ID: 30969260
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Asfotase alfa improved skeletal mineralization and fracture healing in a child with MCAHS.
    Kang M, Wu M, Crane JL.
    Bone; 2023 Jul 15; 172():116778. PubMed ID: 37088336
    [Abstract] [Full Text] [Related]

  • 39. Visualization of Mineral-Targeted Alkaline Phosphatase Binding to Sites of Calcification In Vivo.
    Amadeu de Oliveira F, Narisawa S, Bottini M, Millán JL.
    J Bone Miner Res; 2020 Sep 15; 35(9):1765-1771. PubMed ID: 32343017
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.